, Tracking Stock Market Picks
Enter Symbol:
C.r. Bard, Inc. (BCR) [hlAlert]

Market Perform
down 21.57 %

C.r. Bard, Inc. (BCR) downgraded to Market Perform by BMO Capital Markets

Posted on: Monday,  Apr 13, 2009  8:25 AM ET by BMO Capital Markets

BMO Capital Markets rated Market Perform C.r. Bard, Inc. (NYSE: BCR) on 04/13/2009. Previously BMO Capital Markets rated Outperform C.r. Bard, Inc. (NYSE:
BCR) on 01/07/2008., when the stock price was $95.38. Since then, C.r. Bard, Inc. has lost 21.58% as of 04/13/2009's recent price of $74.80.
If you would have followed the previous BMO Capital Markets's recommendation on BCR, you would have lost 21.57% of your investment in 462 days.

C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas.

The U.S. Equity Research team comprises over 25 analysts located in New York, Atlanta, Boston, Denver, Houston and Los Angeles. We cover more than 375 stocks and also provide equity strategy, quantitative analysis and portfolio management services to our clients. Our goal is to identify the best sectors to invest in, and the best stocks within those sectors, in order to help our clients maximize their portfolio returns. Our award-winning analysts provide research that is informative, perceptive and actionable.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/13/2009 8:25 AM Hold
as of 12/31/2009
1 Week   
1 Month   
3 Months   
1 YTD down  -11.22 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/7/2008 9:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy